StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Stock analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSVGet Free Report) in a report released on Tuesday. The firm set a “hold” rating on the stock.

ObsEva Stock Performance

The business’s fifty day moving average is $0.01 and its 200-day moving average is $0.04. ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The stock has a market cap of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

About ObsEva

(Get Free Report)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Read More

Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.